Andrew Mok
Stock Analyst at Barclays
(2.48)
# 2,224
Out of 4,778 analysts
152
Total ratings
49.07%
Success rate
-2.41%
Average return
Main Sectors:
Stocks Rated by Andrew Mok
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RDNT RadNet | Maintains: Overweight | $74 → $60 | $51.83 | +15.76% | 7 | Mar 24, 2025 | |
| ACHC Acadia Healthcare Company | Downgrades: Equal-Weight | $43 → $35 | $28.94 | +20.94% | 12 | Feb 28, 2025 | |
| ALHC Alignment Healthcare | Maintains: Underweight | $8 → $9 | $17.46 | -48.45% | 4 | Feb 28, 2025 | |
| UHS Universal Health Services | Maintains: Overweight | $271 → $249 | $181.58 | +37.13% | 21 | Feb 27, 2025 | |
| CYH Community Health Systems | Maintains: Equal-Weight | $5 → $4 | $2.76 | +44.93% | 5 | Feb 20, 2025 | |
| DVA DaVita | Maintains: Equal-Weight | $164 → $169 | $150.41 | +12.36% | 10 | Feb 18, 2025 | |
| HUM Humana | Maintains: Equal-Weight | $255 → $270 | $271.72 | -0.63% | 7 | Feb 13, 2025 | |
| THC Tenet Healthcare | Maintains: Overweight | $190 → $161 | $129.49 | +24.33% | 11 | Feb 13, 2025 | |
| CVS CVS Health | Maintains: Overweight | $71 → $73 | $67.57 | +8.04% | 7 | Feb 13, 2025 | |
| MOH Molina Healthcare | Maintains: Equal-Weight | $372 → $339 | $312.65 | +8.43% | 4 | Feb 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $116 → $118 | $99.96 | +18.05% | 14 | Feb 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $420 → $339 | $320.40 | +5.81% | 4 | Jan 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $392 → $366 | $333.84 | +9.63% | 9 | Jan 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $501 → $512 | $427.23 | +19.84% | 6 | Jan 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $655 → $642 | $516.50 | +24.30% | 6 | Jan 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $91 → $93 | $59.34 | +56.72% | 6 | Dec 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $5 → $2 | $4.48 | -55.36% | 2 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $19 → $21 | $23.92 | -12.21% | 6 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $88 → $83 | $90.98 | -8.77% | 2 | Apr 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $35 | $24.39 | +43.50% | 1 | Mar 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sell | $12 | $8.91 | +34.68% | 1 | Dec 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sell | $145 → $95 | $92.74 | +2.44% | 7 | Aug 2, 2022 |
RadNet
Mar 24, 2025
Maintains: Overweight
Price Target: $74 → $60
Current: $51.83
Upside: +15.76%
Acadia Healthcare Company
Feb 28, 2025
Downgrades: Equal-Weight
Price Target: $43 → $35
Current: $28.94
Upside: +20.94%
Alignment Healthcare
Feb 28, 2025
Maintains: Underweight
Price Target: $8 → $9
Current: $17.46
Upside: -48.45%
Universal Health Services
Feb 27, 2025
Maintains: Overweight
Price Target: $271 → $249
Current: $181.58
Upside: +37.13%
Community Health Systems
Feb 20, 2025
Maintains: Equal-Weight
Price Target: $5 → $4
Current: $2.76
Upside: +44.93%
DaVita
Feb 18, 2025
Maintains: Equal-Weight
Price Target: $164 → $169
Current: $150.41
Upside: +12.36%
Humana
Feb 13, 2025
Maintains: Equal-Weight
Price Target: $255 → $270
Current: $271.72
Upside: -0.63%
Tenet Healthcare
Feb 13, 2025
Maintains: Overweight
Price Target: $190 → $161
Current: $129.49
Upside: +24.33%
CVS Health
Feb 13, 2025
Maintains: Overweight
Price Target: $71 → $73
Current: $67.57
Upside: +8.04%
Molina Healthcare
Feb 7, 2025
Maintains: Equal-Weight
Price Target: $372 → $339
Current: $312.65
Upside: +8.43%
Feb 7, 2025
Maintains: Overweight
Price Target: $116 → $118
Current: $99.96
Upside: +18.05%
Jan 31, 2025
Maintains: Overweight
Price Target: $420 → $339
Current: $320.40
Upside: +5.81%
Jan 27, 2025
Maintains: Overweight
Price Target: $392 → $366
Current: $333.84
Upside: +9.63%
Jan 24, 2025
Maintains: Overweight
Price Target: $501 → $512
Current: $427.23
Upside: +19.84%
Jan 17, 2025
Maintains: Overweight
Price Target: $655 → $642
Current: $516.50
Upside: +24.30%
Dec 13, 2024
Maintains: Overweight
Price Target: $91 → $93
Current: $59.34
Upside: +56.72%
Nov 11, 2024
Maintains: Underweight
Price Target: $5 → $2
Current: $4.48
Upside: -55.36%
Nov 8, 2024
Maintains: Equal-Weight
Price Target: $19 → $21
Current: $23.92
Upside: -12.21%
Apr 23, 2024
Downgrades: Underweight
Price Target: $88 → $83
Current: $90.98
Upside: -8.77%
Mar 6, 2024
Initiates: Equal-Weight
Price Target: $35
Current: $24.39
Upside: +43.50%
Dec 8, 2022
Initiates: Sell
Price Target: $12
Current: $8.91
Upside: +34.68%
Aug 2, 2022
Downgrades: Sell
Price Target: $145 → $95
Current: $92.74
Upside: +2.44%